1. Coronavirus Disease 2019 Complicated by Multiple Simultaneous Intracerebral Hemorrhages
- Author
-
Takeshi Tanabe, Masaya Akai, Katsuhiko Sarazawa, Hisaji Imamura, Ryota Motoie, Hiroki Toda, Takahiro Kitahara, Seiichiro Takano, and Kazuto Komatsu
- Subjects
Male ,medicine.medical_specialty ,medicine.drug_class ,medicine.medical_treatment ,Pneumonia, Viral ,Case Report ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Betacoronavirus ,0302 clinical medicine ,COVID-19 Testing ,Fatal Outcome ,Internal medicine ,Internal Medicine ,Coagulopathy ,Extracorporeal membrane oxygenation ,Medicine ,Humans ,Pandemics ,Cerebral Hemorrhage ,Intracerebral hemorrhage ,business.industry ,Cerebral infarction ,Clinical Laboratory Techniques ,SARS-CoV-2 ,Anticoagulant ,anticoagulant ,COVID-19 ,General Medicine ,Middle Aged ,medicine.disease ,intracerebral hemorrhage ,Pneumonia ,hypercoagulability ,Etiology ,Cardiology ,030211 gastroenterology & hepatology ,ECMO ,business ,Complication ,Coronavirus Infections - Abstract
The relationship between coronavirus disease 2019 (COVID-19) and intracerebral hemorrhage remains unclear. We herein report a case of severe COVID-19 pneumonia complicated by multiple simultaneous intracerebral hemorrhages (MSICH). The patient died eight days after the episode of MSICH. No apparent coagulopathy was observed; however, extracorporeal membrane oxygenation and anticoagulation might have caused the occurrence of MSICH. Laboratory findings showed hypercoagulability, suggesting that thrombotic etiologies, such as sinus thrombosis or cerebral infarction, might also have caused MSICH. MSICH can occur as a fatal complication of COVID-19, and this should be considered when providing treatment.
- Published
- 2020